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Abstract
Background: Latent Tuberculosis treatment is a key tuberculosis control intervention. Adolescents are a high risk group 
that is not routinely treated in low income countries. Knowledge of  latent Tuberculosis (TB) burden among adolescents may 
influence policy. 
Objectives: We determined the prevalence and risk factors of  latent TB infection among adolescents in rural Uganda. 
Methods: We analyzed baseline data from a study that assessed the prevalence and incidence of  Tuberculosis disease among 
adolescents. We extracted socio-demographics, medical assessment information, and tuberculin skin test results and estimat-
ed prevalence ratios (PR) of  latent TB infection risk factors by binomial regression.
Results: The prevalence of  latent TB was 16.1%, 95% CI (15.1 – 17.2).  Significant risk factors were: a BCG scar, APR 1.29 
(95% CI 1.12 – 1.48); male gender, APR 1.37 (95% CI 1.21 – 1.56); age   17 -18 years, APR 1.46 (95% CI 1.24 – 1.71) and 
15-16 years, APR 1.25 (95% CI 1.07 – 1.46) compared to 12-14 years; being out of  school, APR 1.31 (95% CI 1.05 – 1.62); 
and a known history of  household TB contact in last 2 years, APR 1.91 (95% CI 1.55 – 2.35) 
Conclusion:  Targeted routine latent TB treatment among adolescents out of  school may be crucial for TB disease control 
in low income countries.
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Introduction
Tuberculosis (TB) is one of  the commonest infectious 
diseases in the world. In 2012 the estimated global bur-
den of  disease was 8.6 million cases1. Considerable TB 
control success has been registered through interrup-
tion of  disease transmission. This has been achieved by 
identifying and treating persons with the disease2,3. Fol-
lowing infection with TB, an individual’s immunity can 
suppress TB organisms to a Latent TB infection (LTBI) 
state. Reactivation may occur many years after infection 
leading to active disease  and has been documented as 
an important source of  new active disease4. Whereas 
high income countries have incorporated the diagnosis 
and treatment of  latent TB infection among all individ-
uals in their TB control programs, low income countries 
usually target this intervention for only HIV infected 
patients and children with a household TB contact5, the 
groups at highest risk of  LTBI reactivation.
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There is a sudden increase of  TB incidence during ad-
olescence, which may be due to an increase in new in-
fections6 or following conversion of  LTBI to active dis-
ease. This makes adolescence suitable for targeted TB 
disease control interventions that prevent progression 
of  LTBI to active disease. Few studies have document-
ed the prevalence and risk factors of  latent TB infection 
among adolescents7-9.  We assessed the prevalence of  
latent TB infection, and it’s risk factors among adoles-
cents in and out of  school in two rural district of  East-
ern Uganda. Knowledge of  the epidemiology of  latent 
TB in this age group is important to guide the design of  
control interventions.
Methods
Study design  
We reviewed baseline data for participants enrolled in 
a prospective cohort study conducted among adoles-
cents to determine the prevalence and incidence of  TB 
disease in the Makerere University School of  Public 
Health Demographic Surveillance Site (DSS) in East-
ern Uganda10. 
 
Enrolment and baseline assessment for main study 
Details of  the main study are published  elsewhere11. 
The main study enrolled adolescents aged 12-18 years 
who had resided in the study area for at least three 
months prior to the study and had no plans of  migrat-
ing were recruited into the main study cohort. A to-
tal of  5000 adolescents were proportionately enrolled 
from three age strata (12-14, 14-16 and 17-18 years) and 
followed-up for at least one year. 
Enrolled study participants were assessed on two occa-
sions either at their residence or school by study nurses. 
At the first assessment, a full medical history and fo-
cused physical examination was done. Information was 
collected on socio-demographics, medical history per-
taining to signs and symptoms of  TB disease, history of  
household contact with a TB patient within two years 
prior to enrolment in the study and history of  smoking, 
alcohol consumption and hospitalization within the last 
six months. Physical examination included inspection 
of  the BCG vaccination site for a scar and TB specific 
signs. All participants had a tuberculin skin test (TST) 
performed by sub-dermal administration of  two units 
of  tuberculin / purified protein derivative (PPD) from 
the Staten’s Serum Institute, Denmark on the volar as-
pect of  the right forearm using the mantoux technique. 
Though it was desirable to perform an HIV test on all 
participants, this was not done due to community con-
cerns. Only participants who had prevalent TB had an 
HIV test performed.
A second assessment visit was done between 48 and 
72 hours after the TST, during which the TST site was 
examined for an induration. The transverse diameter of  
the induration at the site was measured using a trans-
parent ruler and recorded in millimeters (mm). All base-
line procedures were performed under adequate quality 
control measures by study nurses who had undergone 
study tailored training.
 
Interpretation of  TST readings  
TST readings were used to determine whether a partic-
ipant had LTBI or not. A participant was said to have 
LTBI if  they had a positive TST.  A TST was consid-
ered positive if; the transverse skin induration diameter 
was greater than or equal to 5 mm in an HIV infected 
participant, and greater than or equal to 10 mm in a 
participant without HIV infection.
 
Eligibility criteria for this study 
Baseline data of  all participants enrolled in the main 
study was eligible for inclusion in this study. Data of  
participants whose skin induration diameter was not 




Baseline data of  all participants enrolled in the main 
study was extracted from the Microsoft SQL Server 
2008 database into Microsoft Excel 2007 for cleaning. 
Cross tabulation and calculation of  frequencies were 
done using pivot tables to further edit and clean the 
data. A data dictionary was also developed to describe 
values in the variables.
 
Data analysis 
Clean data was then exported to SPSS version 16 for 
univariate analysis. To describe the characteristics of  
the study population, we calculated the frequencies of  
the socio-demographic and predictor variables i.e.  age, 
gender, schooling status, smoking habit, drinking habit, 
hospitalization history in the six months prior to the 
study, HIV sero-status, presence of  a visible BCG scar 
and history of  household contact with a TB patient in 
the last two years. We plotted the distribution of  TST 
reading diameters and later categorized the readings as 
either positive or negative. We calculated the frequency 
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of  baseline positive tuberculin skin test to determine 
the prevalence of  LTBI. 
Data was then exported to STATA version 12 to de-
termine the risk factors of  prevalent LTBI. We used a 
mixed effects binomial model with a logarithmic link 
function to estimate prevalence ratios (PR) for risk fac-
tors of  latent tuberculosis infection (LTBI).   
 
Ethical consideration 
The study was approved by the Makerere University 
School of  Public Health–Higher Degrees and Research 
Ethics committee (HDREC), Kampala Uganda and the 
Uganda National Council of  Science and Technolo-
gy (UNCST). Written informed consent was obtained 
from the parents or legal guardians of  the study partic-
ipants and the adolescents provided assent. 
 
Results 
Enrolment of  participants  
A total of  4981(99.5%) out of  the 5000 adolescents in 
the main study were included in the analysis for this 
study. We excluded 19 participants (0.38 %) from the 
analysis because either they were not available for meas-
urement or the measurement was not done within the 
study stipulated 48 – 72 hours after TST administration. 
 
Characteristics of  participants  
Overall, 2332 (46.8%) of  the study participants were 
12-14 years old, 1475 (29.6%) 15 -16 year old and 1174 
(23.6%) were 17 – 18 years old A total of  4663 (93.6 
%) participants were out of  school, 235 (4.72%) had 
a known history of  a household TB contact within 
two years prior to enrolment, 3230 (64.8%) had a vis-
ible BCG scar; and six participants (0.12%) were HIV 
infected. Details of  the participant characteristics are 
summarized in Table 1.
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Table 1: Characteristics of study population 
Variable  Frequency (n= 4981) Proportion (%) 
Age stratum   
12 – 14 years 2332 46.8 
15 – 16 years 1475 29.6 
17 – 18 years 1174 23.6 
Gender   
Male 2582 51.9 
Schooling status   
In school 4663 93.6 
Smoking habit   
Yes 2 0.04 
Drinking habit   
Yes 11 0.22 
History of hospitalization in last 6 months    
Yes 43 0.86 
HIV sero-status   
HIV infected 4 0.08 
Presence  of BCG scar   
Yes 3230 64.8 
Known history of household contact with TB patient in last 2 years   
Yes 235 4.72 
 
Figure 1: Distribution of TST induration diameter among the study participants∞ 
 
 
∞We excluded 3000 participants with zero TST induration diameters; this graph includes 
TST readings for 1981 participants. 
The prevalence of  LTBI increased progressively by age 
stratum from 37% in the 12-14 years stratum to 41% 
in the 15-16 strata and 47% in the 17-18 age stratum 
(Figure 2). 
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∞We excluded 00  participants with zero TST induration diameters; this graph includes TST readings for 1981 participants.
The distribution of  TST induration diameters showed 
little digit preference, indicating good quality reading; 
and showed a bimodal distribution with 2 peaks, at 6-8 
mm and 12mm (Figure 1). 
Prevalence of  latent TB infection  
The overall prevalence of  latent TB infection (LTBI) 
was 16.1%, (95% confidence interval (CI) 15.1 – 17.2). 




Risk factors of  latent TB infection 
At bivariate analysis: a BCG scar, Male gender, age stra-
ta 15 -16 years, 17 – 18 years, non-school going status, 
and having no household history of  contact with a TB 
patients had significant association with LTBI among 
adolescents (Table 2). 
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At multivariable analysis, the binomial regression model 
was significant (p =0.002). Participants with a visible 
BCG scar (previous BCG vaccination), APR 1.29 (95% 
CI 1.12 – 1.48, p<0.001); male gender, APR 1.37 (95% 
CI 1.21 – 1.56, p<0.001); age strata  17 -18 years, APR 
1.46 (95% CI 1.24 – 1.71, p<0.001 15-16 years, APR 
1.25 (95% CI 1.07 – 1.46) p=0.004, and ; being out of  
school, APR 1.31 (95% CI 1.05 – 1.62, p< 0.014); hav-
ing a  known history of  household TB contact in last 
2 years, APR 1.91 (95% CI 1.55 – 2.35, p<0.001) were 
significant risk factors for latent TB infection among 
the adolescents (Table 3).
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Table 2: Bivariate analysis of association between LTBI and participant characteristics (n=4981)  
Characteristic Participants (N) Participants with LTBI n (%) Crude PR (95% CI)  p-value 
TST Result     
Positive 4981 803 (16.1) 16.1 (15.1 – 17.2)  
BCG scar     
No  1751 233 (13) 1  
Yes 3230 570 (18) 1.33 (1.15 – 1.53) < 0.001 
Hospitalization history     
No 4938 796 (16) 1  
Yes 43 7 (16) 1.01 (0.51 – 1.99)  0.977 
Alcohol Consumption     
No 4970 802 (16) 1.77 (0.27 – 11.51) 0.548 
Yes 11 1 (9) 1   
Gender     
Female 2399 322 (13) 1  
Male 2582 481 (19) 1.39 (1.22 – 1.58) < 0.001 
Age strata     
12 – 14 2332 308 (13) 1  
15 – 16 1475 248 (17) 1.27 (1.09 – 1.48) 0.002 
17 – 18 1174 247 (21) 1.59 (1.37 – 1.85) < 0.001 
Schooling status     
 In school 4663 726 (16) 1  
Out of school 318 77 (24) 1.55 (1.27 – 1.91) < 0.001 
Household TB contact 
history 
    
No 4746 734 (15) 1  
 Yes 235 69 (29) 1.90 (1.54 – 2.34) < 0.001 
HIV infection     
No or Unknown 4975 801 (16) 1  
Infected 6 2 (33) 2.07 ( 0.67 – 6.43) 0.208 
 
Discussion 
In this study conducted in a rural based Iganga-Mayuge 
demographic surveillance site, we found a 16.1% prev-
alence of  LTBI among adolescents aged 12-18 years. 
The risk factors of  prevalent LTBI were: age strata 17 
– 18 and 16 -17 years, male gender, a visible BCG scar, a 
known history of  household TB contact within the last 
2 years and being out of  school.
 
The LTBI prevalence of  16.1% is quite low in compar-
ison to the 42.2% prevalence found among adolescents 
in a South African study where positive TST was de-
fined as TST induration diameter cut off  of  10mm8. 
This is could be due to the higher TB incidence rate in 
South Africa; 857 per 100,000 population compared to 
Uganda’s 175 per 100,000 population1. Given that latent 
TB is a big source of  new active disease4, a higher inci-
dence of  TB disease in South Africa suggests a similar-
ly higher LTBI prevalence than Uganda. Furthermore, 
the lower LTBI prevalence found in our study may be 
related to the rural nature of  the study population that 
is associated with a lower risk of  TB transmission com-
pared to the more urban setting in which the South Af-
rica study was conducted8,10,11.
Use of  two–step TST administration has been found 
to increase LTBI detection; an increase of  11% TST 
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Table 3: Multivariable analysis (n=4981) for predictive factors of Latent TB Infection 
 
Characteristic Crude PR (95% CI)  p-value 
 
 
Adjusted PR  (95% CI) p-value 
BCG scar     
No  1  1  
Yes 1.33 (1.15 – 1.53) < 0.001 1.29 (1.12 – 1.48) 
< 0.001 
Gender 
    
Female 1  1  
Male 1.39 (1.22 – 1.58) < 0.001 1.37 (1.21 – 1.56) < 0.001 
Age strata     
12 – 14 1  1  
15 – 16 1.27 (1.09 – 1.48) 0.002 1.25 (1.07 – 1.46) 0.004 
17 – 18 1.59 (1.37 – 1.85) < 0.001 1.46 (1.24 – 1.71) < 0.001 
Schooling status     
In school 1  1  
Out of school 1.55 (1.27 – 1.91) < 0.001 1.31 (1.05 – 1.62) 0.014 
Household TB 
contact history 
    
 No 1  1  
Yes 1.90 (1.54 – 2.34) < 0.001 1.91 (1.55 – 2.35) < 0.001 
positivity was found when two-step TST was used in 
a recent study conducted in two Columbian prisons12, 
but only 2% increase in LTBI in Indian adolescents13. 
A two-step TST administration was not feasible in our 
community based study and we may thus have under-
estimated the LTBI prevalence in our study population.
Older age was associated with a higher risk of  LTBI 
similar to previous studies involving students7,8. This 
is due to a larger cumulative exposure to patients with 
active TB disease with increasing age, as has been ob-
served in high prevalence countries14,15. 
 
Though schools offer a congregate environment ide-
al for transmission of  respiratory infections, we found 
a higher proportion of  adolescents with LTBI among 
those out of  school than those in school. The adoles-
cents out of  school are more likely to engage in smok-
ing and alcohol consumption which have been found 
to increase the risk for TB infection16,17, although we 
could not confirm that in this study, possibly due to low 
smoking and alcohol consumption in the study popu-
lation. 
The prevalence of  LTBI among the male participants 
was higher than that in the female participants. This is 
no surprise since the global TB disease burden is higher 
among males than females1.  A larger TB disease preva-
lence among males compared to females was also found 
in disease surveys conducted in some high prevalence 
countries like Malawi and Nigeria. This may be attrib-
uted to the higher LTBI prevalence in males and/or 
higher reactivation rate among the males and our study 
seems to indicate the former.
 
We found a significant association between previous 
BCG vaccination and prevalent LTBI in contrast to 
other studies8,18. This could be due to a false positive 
LTBI arising from the BCG reaction with the TST, 
the sole investigation that our study used to determine 
LTBI. The effect of  BCG on TST reactivity has how-
ever been shown to wane off  after 8-10 years19,20.  In 
Uganda BCG is given at birth, therefore a positive TST 
among adolescents is more likely to reflect true LTBI. 
However, TST reactivity to BCG has also been demon-
strated  long after the period that the effect of  the BCG 
vaccination is expected to have waned off20, which may 
explain why our study found more LTBI among adoles-
cents who had a BCG scar (BCG vaccination). Though 
the demonstration of  TST reactivity to BCG vaccina-
tion creates controversy about the use of  TST to meas-
ure LTBI in countries with high BCG coverage, such as 
Uganda21,22, studies that used interferon gamma release 
assays (IGRA’s), that are believed not to be affected by 
BCG have shown no added value in estimation of  LTBI 
in high BCG vaccination areas7,8,22. 
 
The strength of  this study included the use of  clinical 
history coupled with microbiological and radiological 
investigations to exclude active TB disease among all 
participants. We were thus able to identify and exclude 
participants with active TB disease from our analysis to 
provide a more accurate estimate of  LTBI and its risk 
factors. The study also enrolled both school going and 
out of  school adolescents, the findings of  this study 
therefore give information that can be used to make 
disease control interventions that are applicable to both 
categories of  adolescents. 
 
Limitations 
Our inability to differentiate and subsequently exclude 
from analysis positive TST reactions due to non-tuber-
culous mycobacterium (NTM) infection. However the 
TST distribution diameter had two peaks, with the first 
peak at an induration diameter ranging between 6-8 
mm; this first peak most likely represent NTM. The 
TST positivity cut-off  of  10mm could have largely ex-
cluded these reactions due to NTM.  
In our study the BCG scar was used as a proxy to meas-
ure BCG vaccination. However, the use of  the scar may 
not be a reliable proxy, since a part of  children who 
receive BCG vaccination may not develop a scar23,24.
 
The TST induration we used to determine LTBI is a 
cell mediated immune reaction which may be compro-
mised by HIV infection25.  To reduce  false negative 
TST results among HIV infected persons  a TST indu-
ration cut off  diameter of  5mm is recommended26,27. In 
this study, we failed to obtain consent for HIV testing 
and so we did not ascertain HIV status of  all partici-
pants yet we used a TST induration diameter of  10mm 
as a cut off  to determine LTBI on all participants and 
so we may have underestimated the LTBI prevalence 
in our study population. However, more than 50% of  
our study population included adolescents aged 15 - 18 
years, an age group with a very low HIV prevalence 
(1.4%), based on the most recent HIV sero-behavioral 
survey in Uganda28. More so, we expect an even lower 
HIV prevalence in those aged 12 – 14 years29. Thus, 
HIV infection may not have considerably affected the 
LTBI prevalence estimates.  
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Conclusion
Our findings in these rural Eastern Uganda districts 
of  Iganga and Mayuge show that BCG immunization 
(BCG scar) is significantly associated with TST positiv-
ity during adolescence.  Latent TB is significantly high-
er among the non-school going adolescents and those 
with a household contact, even after correction for age 
and sex.  Routine diagnosis and treatment of  Latent TB 
targeting adolescents out of  school may be a crucial in-
tervention for TB disease control in low income coun-
tries. 
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